- Update of Cardiovascular Outcome Trials (CVOTs) in Diabetes - CVOT Summit 20182019 | 1. lékařská fakulta
- Report from the 3rd Cardiovascular Outcome Trial (CVOT) Summit of the Diabetes & Cardiovascular Disease (D&CVD) EASD Study Group2018 | 1. lékařská fakulta
- Report from the 4th Cardiovascular Outcome Trial (CVOT) Summit of the Diabetes & Cardiovascular Disease (D&CVD) EASD Study Group2019 | 1. lékařská fakulta
- Evidence from routine clinical practice: EMPRISE provides a new perspective on CVOTs2019 | 1. lékařská fakulta
- CARMELINA: An important piece of the DPP-4 inhibitor CVOT puzzle2019 | 1. lékařská fakulta
- CVOT Summit 2022 Report: new cardiovascular, kidney, and glycemic outcomes2023 | 1. lékařská fakulta
- Report from the 2nd Cardiovascular Outcome Trial (CVOT) Summit of the Diabetes and Cardiovascular Disease (D&CVD) EASD Study Group2017 | 1. lékařská fakulta
- Report from the 1st Cardiovascular Outcome Trial (CVOT) Summit of the Diabetes & Cardiovascular Disease (D&CVD) EASD Study Group2016 | 1. lékařská fakulta
- Advances in the management of cardiovascular risk for patients with type 2 diabetes: perspectives from the Academy for Cardiovascular Risk, Outcomes and Safety Studies in Type 2 Diabetes2017 | 1. lékařská fakulta
- Relevance of positive cardiovascular outcome trial results in clinical practice: perspectives from the Academy for Cardiovascular Risk, Outcomes and Safety Studies in Type 2 Diabetes (ACROSS T2D)2017 | 1. lékařská fakulta
- Výsledky a praktické výstupy studie REWIND2019 | Publikace bez příslušnosti k fakultě
- SGLT2 inhibitors in T2D and associated comorbidities differentiating within the class2019 | 1. lékařská fakulta
- Co je za poslední dva roky nového v diabetologii?2019 | 1. lékařská fakulta
- Adoption of the ADA/EASD guidelines in 10 Eastern and Southern European countries: Physician survey and good clinical practice recommendations from an international expert panel2021 | 1. lékařská fakulta
- Translating recent results from the Cardiovascular Outcomes Trials into clinical practice: recommendations from the Central and Eastern European Diabetes Expert Group (CEEDEG)2017 | 1. lékařská fakulta
- Beta-blockers for Atherosclerosis Prevention: a Missed Opportunity?2022 | 1. lékařská fakulta